Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Humacyte
HUMA
$148M
| $214K | ﹤0.01% |
353,410
+9,659
| +3% | +$10K |
|
3902
Dimensional International Small Cap ETF
DFIS
$5.9B
| $211K | ﹤0.01% |
+6,257
| New | +$218K |
|
3903
HF Foods Group
HFFG
$97.6M
| $210K | ﹤0.01% |
113,596
+8,500
| +8% | +$16.3K |
|
3904
Dorchester Minerals
DMLP
$1.35B
| $209K | ﹤0.01% |
+7,711
| New | +$196K |
|
3905
American Vanguard Corp
AVD
$62.8M
| $208K | ﹤0.01% |
83,361
+1,167
| +1% | +$4.97K |
|
|
AVBH
3906
Avidbank Holdings
AVBH
$361M
| $207K | ﹤0.01% |
+7,250
| New | +$205K |
|
3907
Invesco S&P MidCap Momentum ETF
XMMO
$7.61B
| $206K | ﹤0.01% |
1,424
-109
| -7% | -$15.8K |
|
3908
NI Holdings
NODK
$313M
| $206K | ﹤0.01% |
16,012
-1,852
| -10% | -$24.6K |
|
3909
Lifezone Metals
LZM
$341M
| $206K | ﹤0.01% |
61,306
-3,404
| -5% | -$15.8K |
|
3910
Invesco Dorsey Wright Momentum ETF
PDP
$1.53B
| $206K | ﹤0.01% |
+1,702
| New | +$211K |
|
3911
Crexendo
CXDO
$217M
| $205K | ﹤0.01% |
33,182
| – | – |
|
3912
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $203K | ﹤0.01% |
11,438
-7,764
| -40% | -$141K |
|
|
NREF
3913
NexPoint Real Estate Finance
NREF
$318M
| $203K | ﹤0.01% |
15,072
-2,070
| -12% | -$29.6K |
|
3914
Expensify
EXFY
$202M
| $201K | ﹤0.01% |
231,584
-2,004
| -0.9% | -$2.38K |
|
3915
iShares MSCI China ETF
MCHI
$6.14B
| $201K | ﹤0.01% |
3,576
-7,081
| -66% | -$425K |
|
3916
Bausch Health
BHC
$2.37B
| $200K | ﹤0.01% |
37,091
-413
| -1% | -$2.47K |
|
3917
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
$790M
| $200K | ﹤0.01% |
+8,717
| New | +$201K |
|
3918
Nuveen Global High Income Fund
JGH
$356M
| $200K | ﹤0.01% |
+16,347
| New | +$207K |
|
3919
Hain Celestial
HAIN
$53.9M
| $198K | ﹤0.01% |
284,415
-1,121
| -0.4% | -$1.04K |
|
3920
SKYX Platforms
SKYX
$148M
| $197K | ﹤0.01% |
175,683
+32,212
| +22% | +$67.2K |
|
3921
Pyxis Oncology
PYXS
$191M
| $196K | ﹤0.01% |
133,996
-31,048
| -19% | -$46.8K |
|
3922
Inter&Co
INTR
$2.3B
| $191K | ﹤0.01% |
23,971
-465
| -2% | -$4.04K |
|
3923
Global Water Resources
GWRS
$256M
| $191K | ﹤0.01% |
25,111
| – | – |
|
3924
Cumberland Pharmaceuticals
CPIX
$118M
| $190K | ﹤0.01% |
58,458
-14,055
| -19% | -$54.2K |
|
3925
Patriot National Bancorp
PNBK
$131M
| $189K | ﹤0.01% |
146,691
+6,598
| +5% | +$9.5K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.